Skip to content

Diagnostic Performance of a Combination of Leukocyte Cell Surface Markers in Predicting the Risk of Severe Bacterial Infection in Febrile Children Under Three Months of Age in the Emergency Department: a Pilot Study.

Diagnostic Performance of a Combination of Leukocyte Cell Surface Markers in Predicting the Risk of Severe Bacterial Infection in Febrile Children Under Three Months of Age in the Emergency Department: a Pilot Study. ( CYTOFEB )

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06618989
Acronym
CYTOFEB
Enrollment
180
Registered
2024-10-01
Start date
2025-02-24
Completion date
2027-09-07
Last updated
2026-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children Under 3 Months of Age With Fever

Keywords

fever, diagnostic, severe bacterial infections

Brief summary

Fever is a frequent reason for emergency department (ED) visits in infants under 3 months of age. Although viral infections are the most common etiologies, the prevalence of severe bacterial infections (SBI) is high (10%). While in infants with SBI, establishing the diagnosis and initiating rapid intravenous antibiotic therapy is necessary, every effort should be made to avoid it in those at low risk of SBI. Clinical examination and biomarkers are still sub-optimal for assessing the risk of SBI. As a result, the vast majority of these children receive inpatient intravenous antibiotic therapy. Flow cytometry is a technique for measuring the expression of biomarkers on the cell surface of leukocytes in response to infection. A French team has identified a combination of some fifteen leukocyte cell surface markers that perform excellently in discriminating between bacterial and viral infections in a population of adults presenting to the emergency department with a suspected infection. However, there are no similar studies in children. The objective of the study is to assess the diagnostic performance of a combination of biomarkers on the cell surface of leukocytes in discriminating between bacterial and viral infection. Infants less than 3 months of age, visiting the ED for fever will have an extra blood sample in order to measure those biomarkers. The performance of those biomarkers to identify SBI will be assessed.

Interventions

OTHERBlood sampling and follow-up call

An additional 1.5 mL of blood will be collected at the time of the child care in the pediatric emergency department. In addition, a telephone call for patient follow-up (unless still hospitalized) will be done.

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER
Pasteur Institute
CollaboratorUNKNOWN
Centre de recherche en épidémiologie et bio statistiques
CollaboratorUNKNOWN
Pitié Salpêtrière Biological Resource Center
CollaboratorUNKNOWN
Centre d'immunologie et des maladies infectieuses
CollaboratorUNKNOWN

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
7 Days to 90 Days
Healthy volunteers
No

Inclusion criteria

* Children aged between 7 and 90 days * Visiting the emergency department with fever (Temperature greater than or equal to 38° measured rectally in the emergency department or reported by parents) OR whose fever is detected during the emergency department visit (Temperature greater than or equal to 38° measured rectally in the emergency department) * Consent signed by one of the two parents/guardians

Exclusion criteria

* Weight less than 2,500 grams * Chronic illness (heart failure...) * Known immune deficiency * Congenital anomaly significantly modifying the probability of bacterial infection (pulmonary malformation, esophageal atresia...) * Antibiotic therapy in the previous 48 hours * Clinically evident source of fever: skin infection, joint infection, etc. * Parents or guardians unable to understand French * Non-affiliation with a social security scheme (including AME)

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic performance of a combination of leukocyte cell surface markers for identifying IBS in febrile infants under 3 months of age presenting to emergency departments.At inclusion (D0)Diagnostic performance (sensitivity and specificity) of the best performing combination of cell surface markers for identifying BSI in febrile infants under 3 months of age presenting to emergency departments.

Countries

France

Contacts

CONTACTMaxime Enault, MD
maxime.enault@aphp.fr+33 171738297
PRINCIPAL_INVESTIGATORMaxime Enault, MD

Sorbonne University, hospitalpediatric emergency department, Trousseau hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 23, 2026